#17,016
Despite ample evidence to the contrary, many people still regard SARS-CoV-2 infection as a simple respiratory infection - not unlike influenza - that only seriously affects the elderly, and those with severe comorbidities.
While it is true that 98%-99% of people survive the acute phase of COVID, the extrapulmonary manifestations of SARS-CoV-2 infection are many, varied, and only partially appreciated.
 |
https://twitter.com/KartikSehgal_MD/status/1281695760879202304 |
As early as the summer of 2020 (see JAMA: Two Studies Linking SARS-CoV-2 Infection To Cardiac Injury), we saw the results of 39 autopsies on COVID cases, that showed that even when pneumonia is the presumed cause of death - and even without overt histopathic evidence of acute myocarditis - the heart often shows a high viral load of SARS-COV-2.
A second, and arguably even more worrisome study, found a remarkable incidence of cardiac injury and myocardial inflammation among a relatively young cohort (avg. age 49 & without pre-existing cardiac hx) of COVID patients who mainly recovered at home but continued to experience a variety of symptoms following their illness.
An accompanying editorial (see Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter? by Clyde W. Yancy, MD, MSc1,2; Gregg C. Fonarow, MD3,4) raised serious concerns over the long-term impact of COVID on public health.
Since then we've seen mounting evidence that - for a significant number of people who survive their initial bout with COVID - they are often left with lingering, and sometimes permanent, cardiac injury (see Nature: Long-term Cardiovascular Outcomes of COVID-19).
As recently as six weeks ago, in More Evidence On The Long-term Impact of SARS-CoV-2 Infection, we looked at a review in the journal Nature on the impact that COVID infection may be having on the cardiac health of survivors.
Tomorrow the CDC will hold a COCA Call for clinicians on dealing with the long-term cardiovascular impacts of COVID infection. These 1-hour presentations are usually technical in nature, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to others.
If you are unable to attend the live presentation, these (and past) webinars are always archived and available for later viewing at this LINK.
Evaluating and Supporting Patients Presenting with Cardiovascular Symptoms Following COVID
Overview
During this COCA Call, presenters will discuss post-COVID conditions (PCC), also referred to as Long COVID or post-acute sequelae of SARS-CoV-2 infection. Post-COVID conditions is an umbrella term for the wide range of health consequences that are present four or more weeks after infection with SARS-CoV-2.Of the variety of symptoms that patients with PCC experience, cardiovascular symptoms and complications are among the most common and debilitating.Presenters will also outline the recommended clinical approach to identifying and managing cardiovascular complications in these patients based on the American Academy of Physical Medicine and Rehabilitation’s (AAPM&R) “Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cardiovascular Complications in PCC”.The burden of PCC is expected to reflect the disproportionate burden of infection by race, ethnicity, and socioeconomic status, and to highlight ongoing inequities in health care healthcare. The AAPM&R Health Equity Work Group has developed guidance to highlight the central role that principles of diversity, equity, and inclusion play in delivering quality health care.
Presenters
Miriam Nji, MD, MPH
Medical Epidemiologist
Post-COVID Conditions Team
Chronic Viral Diseases Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Jonathan Whiteson, MD, FAAPMR
Medical Director, Cardiac and Pulmonary Rehabilitation
Co-Director, NYU Post COVID Care Program
Rusk Rehabilitation, NYU Langone Health
Alba Azola, MD, FAAPMR
Assistant Professor
Co-director of the Post-Acute COVID-19 Team (JH PACT) Program
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Call Materials
Not available at this time. Please check back.
Call Details
When:
Tuesday, September 20, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1611481743
Webinar ID: 161 148 1743
Passcode: 756232
Telephone:
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
International numbers
One-tap mobile:
US: +16692545252,,1611481743#,,,,*756232# or +16468287666,,1611481743#,,,,*756232#
